Natural Alternatives director awarded 8,000 shares
Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Alan G. Dunn received a grant of 8,000 shares of Common Stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. One-third vests on March 7, 2027, another third on March 7, 2028, and the final third on March 7, 2029. Following this award, he directly holds 99,211 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 8,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. This transaction represents a grant of restricted stock to an outside Director pursuant to the Issuer's 2020 Omnibus Incentive Plan.
- F2. One third (2,667 shares) of the restricted stock vests on March 7, 2027; one third (2,667 shares) of the restricted stock vests on March 7, 2028, and the final third (2,666 shares) of the restricted stock vests on March 7, 2029.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NAII director Alan G. Dunn report?
Was the NAII Form 4 transaction an open-market purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.